Neovascular (Wet) Age-Related Macular Degeneration
Ophthalmology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
4D Molecular Therapeutics4D-150 IVT
Clinical Trials (1)
Total enrollment: 215 patients across 1 trials
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Start: Dec 2021Est. completion: Jan 2031215 patients
Phase 1/2Recruiting
Related Jobs in Ophthalmology
Lead Data Manager
Genomics
Remote
4h ago
Cleanroom and Laboratory Technician
SAB BIO
4h ago
Product Specialist
Johnson & Johnson
Hangzhou, Zhejiang, China
20h ago
BM 喀什 PSR HY
Johnson & Johnson
Urumqi, Xinjiang, China
20h ago
Site Delivery Leader MLL
Johnson & Johnson
Gent, East Flanders, Belgium
20h ago
Clinical Operations Manager
Johnson & Johnson
Irvine, California, United States of America
20h ago
$117K - $201K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 215 patients
1 companies competing in this space